| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Ablation versus Anti-Arrhythmic Therapy for Reducing All Hospital Episodes from Recurrent Atrial Fibrillation (AVATAR-AF): Design and rationale
|
Mann, Ian
|
|
|
214 |
C |
p. 36-45
|
artikel
|
| 2 |
A protocol update of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 trial: A comparison of fractional flow reserve–guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease
|
Zimmermann, Frederik M.
|
|
|
214 |
C |
p. 156-157
|
artikel
|
| 3 |
Assessing cardiac safety in oncology drug development
|
Seltzer, Jonathan H
|
|
|
214 |
C |
p. 125-133
|
artikel
|
| 4 |
Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease—A trial protocol for the CARSK study
|
Ying, Tracey
|
|
|
214 |
C |
p. 175-183
|
artikel
|
| 5 |
Creatinine versus cystatin C to estimate glomerular filtration rate in adults with congenital heart disease: Results of the Boston Adult Congenital Heart Disease Biobank
|
Opotowsky, Alexander R.
|
|
|
214 |
C |
p. 142-155
|
artikel
|
| 6 |
De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status
|
Qintar, Mohammed
|
|
|
214 |
C |
p. 1-8
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
214 |
C |
p. v
|
artikel
|
| 8 |
Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF)
|
Lindenfeld, JoAnn
|
|
|
214 |
C |
p. 18-27
|
artikel
|
| 9 |
Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data Registry
|
Fanaroff, Alexander C.
|
|
|
214 |
C |
p. 184-193
|
artikel
|
| 10 |
Information for Readers
|
|
|
|
214 |
C |
p. vi
|
artikel
|
| 11 |
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States
|
Gaziano, Thomas A.
|
|
|
214 |
C |
p. 77-87
|
artikel
|
| 12 |
Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA) and coronary stents: A case study in the analysis and reporting of clinical trials
|
Gelman, Andrew
|
|
|
214 |
C |
p. 54-59
|
artikel
|
| 13 |
Outcomes of left main revascularization in patients with acute coronary syndromes and stable ischemic heart disease: Analysis from the EXCEL trial
|
Doucet, Serge
|
|
|
214 |
C |
p. 9-17
|
artikel
|
| 14 |
Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude
|
Papoutsidakis, Nikolaos
|
|
|
214 |
C |
p. 28-35
|
artikel
|
| 15 |
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry
|
Nanna, Michael G.
|
|
|
214 |
C |
p. 113-124
|
artikel
|
| 16 |
Racial differences in long-term outcomes among black and white patients with drug-eluting stents
|
Sullivan II, Lonnie T.
|
|
|
214 |
C |
p. 46-53
|
artikel
|
| 17 |
Rational and design of the INtentional COronary revascularization versus conservative therapy in patients undergOing successful peripheRAl arTEry revascularization due to critical limb ischemia trial (INCORPORATE trial)
|
Toth, G.
|
|
|
214 |
C |
p. 107-112
|
artikel
|
| 18 |
Rationale and design of DanGer shock: Danish-German cardiogenic shock trial
|
Udesen, Nanna Junker
|
|
|
214 |
C |
p. 60-68
|
artikel
|
| 19 |
Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy
|
Kedhi, Elvin
|
|
|
214 |
C |
p. 134-141
|
artikel
|
| 20 |
Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing
|
Quast, Anne-Floor B.E.
|
|
|
214 |
C |
p. 167-174
|
artikel
|
| 21 |
Risk factors and prognostic impact of left ventricular assist device–associated infections
|
Tattevin, Pierre
|
|
|
214 |
C |
p. 69-76
|
artikel
|
| 22 |
Role of diabetes and insulin use in the risk of stroke and acute myocardial infarction in patients with atrial fibrillation: A Medicare analysis
|
Mentias, Amgad
|
|
|
214 |
C |
p. 158-166
|
artikel
|
| 23 |
Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial
|
Alexandre, Joachim
|
|
|
214 |
C |
p. 88-96
|
artikel
|
| 24 |
Table of Contents
|
|
|
|
214 |
C |
p. i-iv
|
artikel
|
| 25 |
Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015
|
Puymirat, Etienne
|
|
|
214 |
C |
p. 97-106
|
artikel
|
Tijdschrift beschrijving